Randevu Al

OKULLAR/EĞİTİMLER

Sivas Cumhuriyet Üniversitesi Tıp Fakültesi 2005

Sivas Cumhuriyet Üniversitesi Tıp Fakültesi Hastanesi Dahiliye Ana Bilim Dalı 2011-2015

DENEYİM

Bolu İzzet Baysal Devlet Hastanesi Dahiliye  Uzmanı 2015-2017

Kayseri Erciyes Üniversitesi Tıp Fakültesi Hastanesi Gastroenteroloji Ana Bilim Dalı 2017-2018

Erzurum Atatürk Üniversitesi Tıp Fakültesi Hastanesi Tıbbi Onkoloji Ana Bilim Dalı Tıbbi Onkoloji Uzmanı 2018-2021

Şanlıurfa Mehmet Akif İnan EAH Tıbbi Onkoloji Doçenti 2021-2023 

Şanlıurfa Özel Nev Hospital Tıbbi Onkoloji Doçenti 2023 Halen 

BİLİMSEL VE MESLEKİ KURULUŞLARA ÜYELİKLER

Türk Tıbbi Onkoloji Derneği

Avrupa Tıbbi Onkoloji Derneği (ESMO) 

ULUSAL HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER 

YILMAZ ALİ, TEKİN SALİM BAŞOL, BİLİCİ MEHMET, YILMAZ HATİCE (2020). Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer. Acta Oncologica Turcica, 53(3), 402-409., Doi: 10.5505/aot.2020.38981

YILMAZ ALİ, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2020). Survival Analysis and Prognostic Factors in Prostate Cancer Patients: A Single Center Experience in Eastern Anatolia. Dicle Tıp Dergisi, 47(4), 796-805., Doi: 10.5798/dicletip.850364

MİRİLİ CEM, YILMAZ ALİ, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2019). Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey. Dicle Tıp Dergisi, 46(4), 857-865., Doi: 10.5798/dicletip.579312

MİRİLİ CEM, PAYDAŞ SEMRA, YILMAZ ALİ, OĞUL ALİ, BÜYÜKŞİMŞEK MAHMUT, YETİŞİR ABDULLAH EVREN, TOHUMCUOĞLU MERT (2019). Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI). ACTA ONCOLOGICA TURCICA, 52(3), 372-378., Doi: 10.5505/aot.2019.08760

KAÇAN TURGUT, AKGÜL BABACAN NALAN, KILIÇKAP SAADETTİN, ŞEKER MEHMET METİN, YÜCEL BİRSEN, UNCU TUNAHAN, YILMAZ ALİ (2013). Non-metastatik mide kanserli olgularda prognostik faktörler. Cumhuriyet Tıp Dergisi, 35(3), 326-331., Doi: 10.7197/1305-0028.19

AKGÜL BABACAN NALAN, KILIÇKAP SAADETTİN, KAÇAN TURGUT, ŞEKER MEHMET METİN, YÜCEL BİRSEN, YILMAZ ALİ (2013). Port site recurrence of gallbladder cancer after laparoscopic cholecystectomy. Cumhuriyet Tıp Dergisi, 35(2), 286-290., Doi: 10.7197/1305-0028.1981

ULUSLARARASI HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER

KARACİN CENGİZ, SUNAR VELİ, URAKÇI ZUHAT, YILMAZ ALİ (2024). Efficacy and safety of  bevacizumab in patients with low-grade serous ovarian cancer. Future Oncol. 2024 Feb;20(4):207-214.  doi: 10.2217/fon-2023-0763. Epub 2024 Feb 8.

BÜYÜKBAYRAM MEHMET EMİN, HANNARİCİ ZEKERİYA, YILMAZ ALİ, TURHAN AYKUT (2024). Inflammatory parameters in NSCLC with driver mutation. Lung Cancer Manag. 2024 May    16;13(1):LMT66. doi: 10.2217/lmt-2023-0014. eCollection 2024.

 HANNARİCİ ZEKERİYA, YILMAZ ALİ, BÜYÜKBAYRAM MEHMET EMİN, TURHAN AYKUT, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2022). Lipegfilgrastim may cause hyperleukocytosis. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, Doi: 10.1177/10781552221082645

HANNARİCİ ZEKERİYA, YILMAZ ALİ, BÜYÜKBAYRAM MEHMET EMİN, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2021). A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio. Melanoma Research, 31(6), 566-574., Doi: 10.1097/CMR.0000000000000785

YILMAZ ALİ, GÖKÇEN PINAR, YILMAZ HATİCE, HÜZMELİ CAN, YILMAZ ABDULKERİM (2021) Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening.       The       Eurasian           Journal             of         Medicine,         53(3), 220-226.,         Doi: 10.5152/eurasianjmed.2021.20412

YILMAZ HATİCE, DEMİRAĞ GÜZİN, YILMAZ ALİ (2021). Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib. Journal of Pharmacy and Pharmaceutical Sciences, 24, 148-152., Doi: 10.18433/jpps31425

YILMAZ ALİ, ŞİMŞEK MELİH, HANNARİCİ ZEKERİYA, BÜYÜKBAYRAM MEHMET EMİN, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2021). The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib. Future Oncology, 17(33), 45454559., Doi: 10.2217/fon-2021-0457

YILMAZ HATİCE, YILMAZ ALİ, DEMİRAĞ GÜZİN (2021). Prognostic significance of hemoglobin-tored cell distribution width ratio in patients with metastatic renal cancer. Future Oncology, 17(29), 3853-3864., Doi: 10.2217/fon-2021-0040

YILMAZ HATİCE, DEMİRAĞ GÜZİN, SÜLLÜ YURDANUR, YILMAZ ALİ (2021). Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 31(5), 546-552., Doi: 10.29271/jcpsp.2021.05.546

YILMAZ ALİ, MİRİLİ CEM, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2020). Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 35(2), 351-353., Doi: 10.1007/s00384-019-03454-4

YILMAZ ALİ, MİRİLİ CEM, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2020). Possible atezolizumabassociated acute kidney injury and immune thrombocytopenia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 26(7), 1791-1794., Doi: 10.1177/1078155220913081

MİRİLİ CEM, YILMAZ ALİ (2020). Coexistence of anal malignant melanoma and papillary renal cell cancer: An interesting coexistence. Journal of Cancer Research and Therapeutics, 16(1), 189-191., Doi: 10.4103/jcrt.JCRT_370_19

YILMAZ ALİ, TEKİN SALİM BAŞOL, BİLİCİ MEHMET, YILMAZ HATİCE (2020). The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer. LUNG, 198(4), 695-704., Doi: 10.1007/s00408-020-00361-2

YILMAZ ALİ, YILMAZ HATİCE, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2020). The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer. BIOMARKERS IN MEDICINE, 14(9), 727-738., Doi: 10.2217/bmm-2020-0045

YILMAZ ALİ, MİRİLİ CEM, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2020). The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. IRISH JOURNAL OF MEDICAL SCIENCE, 189(1), 91-102., Doi: 10.1007/s11845-019-02153-x

MİRİLİ CEM, KAHRAMAN ÇİĞDEM, YILMAZ ALİ, BİLİCİ MEHMET, TEKİN SALİM BAŞOL, TATAR ABDULGANİ, YAKAR ÖMER, ERCOŞKUN PELİN (2019). Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results. Medical Science and Discovery, 6(12), 327-332., Doi: https://doi.org/10.36472/msd.v6i12.330

MİRİLİ CEM, PAYDAŞ SEMRA, KORKMAZ KAPUKAYA TUBA, YILMAZ ALİ (2019). Systemic immuneinflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. BIOMARKERS IN MEDICINE, 13(18), 1565-1575., Doi: 10.2217/bmm-2019-0303

YILMAZ ALİ, MİRİLİ CEM, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2019). A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII). JOURNAL OF BUON, 24(5), 2127-2135.

MİRİLİ CEM, YILMAZ ALİ, DEMİRKAN SERKAN, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2019). Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 24(10), 1301-1310., Doi: 10.1007/s10147-019-01461-7

 HÜZMELİ CAN, CANDAN FERHAN, BAĞCI GÖKHAN, ALAYGUT DEMET, YILMAZ ALİ, GEDİKLİ MUSTAFA ASIM, BAĞCI BİNNUR, TİMÜÇİN MERYEM, SEZGİN İLHAN, KAYATAŞ MANSUR (2017). Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary           glomerulonephritis.      CLINICAL             RHEUMATOLOGY,          36(11),            2589-2594.,     Doi: 10.1007/s10067-017-3701-y      

ŞEKER MEHMET METİN, DEVECİ KÖKSAL, ŞEKER AYŞE, SANCAKDAR ENVER, YILMAZ ALİ, TÜRESİN AHMET KERİM, KAÇAN TURGUT, AKGÜL BABACAN NALAN (2015). Predictive role of neutrophil gelatinase-associated lipocalin in early diagnosis of platin-induced renal injury. Asian Pacific Journal of Cancer Prevention, 16(2), 407-410., Doi: 10.7314/apjcp.2015.16.2.407.